BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 24236830)

  • 1. Paroxysmal nocturnal haemoglobinuria phenotype cells and leucocyte subset telomere length in childhood acquired aplastic anaemia.
    Tutelman PR; Aubert G; Milner RA; Dalal BI; Schultz KR; Deyell RJ
    Br J Haematol; 2014 Mar; 164(5):717-21. PubMed ID: 24236830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation of aplastic anemia with paroxysmal nocturnal hemoglobinuria clone to childhood B-cell precursor acute lymphoblastic leukemia.
    Wypyszczak K; Urbanska Z; Miarka-Walczyk K; Kolodrubiec J; Jakubowska J; Spychalska J; Glodkowska-Mrowka E; Ussowicz M; Mlynarski W; Pastorczak A
    Pediatr Blood Cancer; 2024 Jul; 71(7):e30994. PubMed ID: 38605541
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute Hæmoglobinuria and Anæmia in a Boy.
    Weber FP
    Proc R Soc Med; 1935 May; 28(7):831. PubMed ID: 19990292
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study.
    Kulagin A; Lisukov I; Ivanova M; Golubovskaya I; Kruchkova I; Bondarenko S; Vavilov V; Stancheva N; Babenko E; Sipol A; Pronkina N; Kozlov V; Afanasyev B
    Br J Haematol; 2014 Feb; 164(4):546-54. PubMed ID: 24261566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell transplantation of matched sibling donors compared with immunosuppressive therapy for acquired severe aplastic anaemia: a Cochrane systematic review.
    Peinemann F; Labeit AM
    BMJ Open; 2014 Jul; 4(7):e005039. PubMed ID: 25031191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic characterization of acquired aplastic anemia by targeted sequencing.
    Heuser M; Schlarmann C; Dobbernack V; Panagiota V; Wiehlmann L; Walter C; Beier F; Ziegler P; Yun H; Kade S; Kirchner A; Huang L; Koenecke C; Eder M; Brümmendorf TH; Dugas M; Ganser A; Thol F
    Haematologica; 2014 Sep; 99(9):e165-7. PubMed ID: 24907358
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of Paroxysmal Nocturnal Hemoglobinuria-Type Bone Marrow Mast Cells.
    Savaşan S; Özdemir Ö; Gadgeel M
    Cureus; 2023 Sep; 15(9):e44919. PubMed ID: 37814756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation of long-term outcome of rabbit anti-thymocyte globulin and cyclosporine therapy for pediatric severe aplastic anemia.
    Chang L; Yan M; Zhang J; Liu B; Zhang L; Guo Y; Sun J; Wan Y; Yi M; Lan Y; Cai Y; Ren Y; Zheng H; Zhang A; Li Z; Wang J; Li Y; Zhu X
    Blood Sci; 2023 Jul; 5(3):180-186. PubMed ID: 37546712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood aplastic anaemia with paroxysmal nocturnal haemoglobinuria clones: A retrospective single-centre study in South Africa.
    Hendricks CL; Naidoo A; Thejpal R; Rapiti N; Neethling B; Goga Y; Buldeo S
    Afr J Lab Med; 2022; 11(1):1537. PubMed ID: 35811748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The GPI-anchored protein CD109 protects hematopoietic progenitor cells from undergoing erythroid differentiation induced by TGF-β.
    Tanabe M; Hosokawa K; Nguyen MAT; Nakagawa N; Maruyama K; Tsuji N; Urushihara R; Espinoza L; Elbadry MI; Mohiuddin M; Katagiri T; Ono M; Fujiwara H; Chonabayashi K; Yoshida Y; Yamazaki H; Hirao A; Nakao S
    Leukemia; 2022 Mar; 36(3):847-855. PubMed ID: 34743190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time and residual hematopoiesis are crucial for PNH clones escape in hepatitis-associated aplastic anemia.
    Yang W; Zhao X; Peng G; Zhang L; Jing L; Zhou K; Li Y; Ye L; Li Y; Li J; Fan H; Yang Y; Zhang F
    Ann Hematol; 2021 Oct; 100(10):2435-2441. PubMed ID: 34269836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical significance of PNH-phenotype cells accounting for < 0.01% of total granulocytes detected by the Clinical and Laboratory Standards Institute methods in patients with bone marrow failure.
    Hosokawa K; Ishiyama K; Ikemoto T; Sugimori C; Noji H; Shichishima T; Obara N; Chiba S; Ninomiya H; Nguyen MAT; Shirasugi Y; Nakamura Y; Ando K; Ueda Y; Yonemura Y; Kawaguchi T; Nishimura JI; Kanakura Y; Nakao S
    Ann Hematol; 2021 Aug; 100(8):1975-1982. PubMed ID: 33095337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of 172 children with severe aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine.
    Lan Y; Chang L; Yi M; Cai Y; Feng J; Ren Y; Liu C; Chen X; Wang S; Guo Y; Zhang A; Liu L; Zhang J; Zhu X
    Ann Hematol; 2021 Jan; 100(1):53-61. PubMed ID: 33033910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress in prediction and recovery of immunosuppressive therapy in patients with severe aplastic anemia].
    Ding SX; Fu R
    Zhonghua Xue Ye Xue Za Zhi; 2018 Nov; 39(11):960-964. PubMed ID: 30486598
    [No Abstract]   [Full Text] [Related]  

  • 15. Updated Guidelines for the Treatment of Acquired Aplastic Anemia in Children.
    Yoshida N; Kojima S
    Curr Oncol Rep; 2018 Jun; 20(9):67. PubMed ID: 29961134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and Treatment of Aplastic Anemia.
    Peslak SA; Olson T; Babushok DV
    Curr Treat Options Oncol; 2017 Nov; 18(12):70. PubMed ID: 29143887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in understanding clonal haematopoiesis in aplastic anaemia.
    Stanley N; Olson TS; Babushok DV
    Br J Haematol; 2017 May; 177(4):509-525. PubMed ID: 28107566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are mild/moderate acquired idiopathic aplastic anaemia and low-risk myelodysplastic syndrome one or two diseases or both and how should it/they be treated?
    Nakao S; Gale RP
    Leukemia; 2016 Nov; 30(11):2127-2130. PubMed ID: 27585953
    [No Abstract]   [Full Text] [Related]  

  • 19. Biomarkers for predicting clinical response to immunosuppressive therapy in aplastic anemia.
    Narita A; Kojima S
    Int J Hematol; 2016 Aug; 104(2):153-8. PubMed ID: 27091471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia.
    Narita A; Muramatsu H; Sekiya Y; Okuno Y; Sakaguchi H; Nishio N; Yoshida N; Wang X; Xu Y; Kawashima N; Doisaki S; Hama A; Takahashi Y; Kudo K; Moritake H; Kobayashi M; Kobayashi R; Ito E; Yabe H; Ohga S; Ohara A; Kojima S;
    Haematologica; 2015 Dec; 100(12):1546-52. PubMed ID: 26315930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.